Diplomat Pharmacy, Inc. (NYSE:DPLO) announced review of strategic alternatives. Diplomat pharmacy strategic alternatives expected to be considered include, but are not limited to, a sale or merger of company. Diplomat pharmacy has retained Foros Securities LLC as financial advisor, Sidley Austin LLP as legal advisor to assist with strategic alternatives review. "We are focused on growing our Specialty business with health plans and hospital systems, positioning the PBM business for growth and improving operating efficiency, while maintaining high standards of patient and customer care," said Brian Griffin, Chairman and CEO of Diplomat. "At the same time, the Board believes that a broad review of strategic alternatives is in the best interests of the Company and our shareholders."